May 31 (Reuters) - The U.S. Food and Drug Administration

has approved Moderna's ( MRNA ) next-generation COVID-19 vaccine

for all individuals aged 65 and above, the company said on

Saturday, the first endorsement since the regulator tightened

requirements.

The vaccine has also been approved for individuals aged

12 to 64 with at least one or more underlying risk factors,

Moderna ( MRNA ) said in a statement.